The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Green, A. Richard, Mechan, Annis O., Elliott, J. Martin, O’Shea, Esther, Colado, M. Isabel·2003·Pharmacological Reviews
DOI 10.1124/pr.55.3.3

Cited by (1,000)

Items 301–400 of 1,000

  1. Binge administration of 3,4-methylenedioxymethamphetamine (“ecstasy”) impairs the survival of neural precursors in adult rat dentate gyrus
    Vicente Hernández‐Rabaza, Laura Domínguez‐Escribá, Juan Antonio Barcia, Jesús Rosel, Francisco Javier Romero, José Manuel García‐Verdugo, Juan J. Canales · 2006 · Neuropharmacology
  2. A Metabolomics Study of Retrospective Forensic Data from Whole Blood Samples of Humans Exposed to 3,4-Methylenedioxymethamphetamine: A New Approach for Identifying Drug Metabolites and Changes in Metabolism Related to Drug Consumption
    Kirstine Lykke Nielsen, Rasmus Telving, Mette Findal Andreasen, Jørgen Bo Hasselstrøm, Mogens Johannsen · 2015 · Journal of Proteome Research
  3. Oligomerization of Neurotransmitter Transporters: A Ticket from the Endoplasmic Reticulum to the Plasma Membrane
    Hesso Farhan, Michael Freissmuth, Harald H. Sitte · 2006 · Handbook of experimental pharmacology
  4. Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicity
    Helena Carmo, Marc Brulport, Matthias Hermes, Franz Oesch, Renata Silva, Luísa Maria Ferreira, Paula S. Branco, Douwe de Boer, Fernando Remião, Félix Dias Carvalho et al. · 2006 · Pharmacogenetics and Genomics
  5. Cannabis Coadministration Potentiates the Effects of “Ecstasy” on Heart Rate and Temperature in Humans
    Glenn Dumont, Cornelis Kramers, Fred C.G.J. Sweep, Daan Johannes Touw, J. G. Coen van Hasselt, M. de Kam, J M van Gerven, Jan K. Buitelaar, Robbert Jan Verkes · 2009 · Clinical Pharmacology & Therapeutics
  6. Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse
    Schenk, Susan, Highgate, Quenten · 2021 · Journal of Neurochemistry
  7. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA (‘ecstasy’) when housed at high ambient temperature
    Kathryn S. Saadat, Esther O’Shea, María Isabel Colado, J. Martin Elliott, A. Richard Green · 2005 · Psychopharmacology
  8. Development and validation of a disk solid phase extraction and gas chromatography–mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat
    Bruno Spinosa De Martinis, Allan J. Barnes, Karl B. Scheidweiler, Marilyn Ann Huestis · 2007 · Journal of Chromatography B
  9. Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, “Ecstasy”) and its reversal by clozapine
    Youichirou Ootsuka, Eugene Nalivaiko, William Walter Blessing · 2004 · Brain Research
  10. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) on BDNF mRNA expression in rat frontal cortex and hippocampus
    Rebeca Martínez-Turrillas, Sonia Moyano, Joaquı́n Del Rı́o, Diana Frechilla · 2006 · Neuroscience Letters
  11. Enzymatic–nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity
    Irene Riezzo, Daniela Cerretani, Carmela Fiore, Stefania Bello, Fabio Centini, Stefano D’Errico, Anna Ida Fiaschi, Giorgio Giorgi, Margherita Neri, Cristoforo Pomara et al. · 2009 · Journal of Neuroscience Research
  12. Critical Role of Peripheral Vasoconstriction in Fatal Brain Hyperthermia Induced by MDMA (Ecstasy) under Conditions That Mimic Human Drug Use
    Eugene A. Kiyatkin, A. H. Kim, Ken T. Wakabayashi, Michael H. Baumann, Yavin Shaham · 2014 · Journal of Neuroscience
  13. Differential effects of MDMA and scopolamine on working versus reference memory in the radial arm maze task
    C. Kay, David N. Harper, Maree J. Hunt · 2009 · Neurobiology of Learning and Memory
  14. Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats
    Sanna Kurling, Aino Kankaanpää, Timo Seppαlä · 2008 · Behavioural Brain Research
  15. The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance
    Elisabet Cuyàs, Antonio Verdejo‐García, Ana Beatriz Fagundo, Olha Khymenets, Joan Carles Rodríguez, Aida Cuenca‐Royo, Susana de Sola Llopis, Klaus Langohr, Jordi Peña‐Casanova, Marta Torrens et al. · 2011 · PLoS ONE
  16. Role of the Dopaminergic System in the Acquisition, Expression and Reinstatement of MDMA-Induced Conditioned Place Preference in Adolescent Mice
    Antonio Vidal‐Infer, C. Roger-Sánchez, Manuel Daza‐Losada, M.A. Aguilar, José Miñarro, Marta Rodríguez‐Arias · 2012 · PLoS ONE
  17. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain
    Anna M. S. Kindlundh-Högberg, Per Svenningsson, H. B. Schiöth · 2006 · Neuropharmacology
  18. Deaths involving serotonergic drugs
    J. L. Pilgrim, Dimitri Gerostamoulos, Olaf H. Drummer · 2010 · Forensic Science International
  19. NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment
    Sonia Moyano, Diana Frechilla, J. Del R�o · 2004 · Psychopharmacology
  20. Ethanol, 3,4-Methylenedioxymethamphetamine (Ecstasy) and Their Combination: Long-Term Behavioral, Neurochemical and Neuropharmacological Effects in the Rat
    Jean‐Christophe Cassel, Céline Riegert, Susanne Rutz, Julie Koenig, Katharina Rothmaier, Brigitte Cosquer, Christine Lazarus, Anja Birthelmer, Hélène Jeltsch‐David, Byron C. Jones et al. · 2005 · Neuropsychopharmacology
  21. Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice
    Nadia Benturquia, Cindie Courtin, Florence Noble, Cynthia Marie-claire A · 2008 · Brain Research
  22. Microglial and astroglial activation by 3,4‐methylenedioxymethamphetamine ( MDMA ) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility
    Lucia Frau, Nicola Simola, Antonio Plumitallo, Micaela Morelli · 2012 · Journal of Neurochemistry
  23. Phosphodiesterase 5 inhibitors prevent 3,4‐methylenedioxymethamphetamine‐induced 5‐HT deficits in the rat
    Elena Puerta, Isabel Hervías, Beatriz Goñi‐Allo, Berta Lasheras, Joaquı́n Jordán, Norberto Aguirre · 2008 · Journal of Neurochemistry
  24. Cardiovascular toxicity of novel psychoactive drugs: Lessons from the past
    Patrick Dawson, James D. Moffatt · 2012 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  25. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter
    Christian Pifl, Harald Reither, Oleh Hornykiewicz · 2015 · European Journal of Pharmacology
  26. Effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity
    Dominik K. Biezonski, Jerrold S. Meyer · 2009 · Journal of Neurochemistry
  27. Comparative Effects of Substituted Amphetamines (PMA, MDMA, and METH) on Monoamines in Rat Caudate
    B. Gough, Syed Z. Imam, Bruce E. Blough, William Slikker, Syed F. Ali · 2002 · Annals of the New York Academy of Sciences
  28. The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity
    Beatriz Goñi‐Allo, Brian Ó. Mathúna, Mireia Segura, Elena Puerta, Berta Lasheras, Rafael de la Torre, Norberto Aguirre · 2007 · Psychopharmacology
  29. Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice
    Helena Pontes, José Alberto Duarte, Paula Guedes de Pinho, Maria Elisa Soares, Eduarda G. R. Fernandes, Ricardo Jorge Dinis‐Oliveira, Carla Sousa, Renata Silva, Helena Carmo, Susana I.P. Casal et al. · 2008 · Toxicology
  30. MDMA (‘Ecstasy’) and methamphetamine combined: Order of administration influences hyperthermic and long-term adverse effects in female rats
    Kelly J. Clemens, Jennifer Louise Cornish, Kong M. Li, Glenn E. Hunt, Iain S. McGregor · 2005 · Neuropharmacology
  31. CB1Cannabinoid Receptor Modulates 3,4-Methylenedioxymethamphetamine Acute Responses and Reinforcement
    Clara Touriño, Catherine A. Ledent, Rafael J. Maldonado, Olga Valverde · 2007 · Biological Psychiatry
  32. Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test
    Rómeó D. Andó, Anita Benkő, Linda Ferrington, Eszter Kirilly, Paul A.T. Kelly, György Bagdy · 2006 · Neuropharmacology
  33. Proton magnetic resonance spectroscopy in ecstasy (MDMA) users
    Jörg Daumann, Thomas Fischermann, Ulrich Pilatus, Armin K. Thron, Walter Moeller‐Hartmann, Euphrosyne Gouzoulis‐Mayfrank · 2004 · Neuroscience Letters
  34. Multiple molecular and neuropharmacological effects of MDMA (Ecstasy)
    Rabi Simantov · 2003 · Life Sciences
  35. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis
    Rüssel S. Falck, Jichuan Wang, Robert Gideon Carlson · 2007 · Journal of Psychopharmacology
  36. Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats
    Kevin T. Ball, Mylissa M. Slane · 2012 · Psychopharmacology
  37. Treatment with MDMA from P11–20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats
    Matthew R. Skelton, Michael T. Williams, Charles V. Vorhees · 2006 · Psychopharmacology
  38. PARADOXICAL FACILITATION: THE RESOLUTION OF FOREIGN ACCENT SYNDROME AFTER CEREBELLAR STROKE
    D. A. Cohen, Kathleen Mary Kurowski, Megan S. Steven, Sheila E. Blumstein, A. Pascual-Leone · 2009 · Neurology
  39. Development and Characterization of a Novel Animal Model of Intermittent MDMA (“Ecstasy”) Exposure during Adolescence
    Jerrold S. Meyer, Brian J. Piper, Valerie E. Vancollie · 2008 · Annals of the New York Academy of Sciences
  40. High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)-induced Fos expression in a region-specific manner
    Garth A. Hargreaves, Glenn E. Hunt, Jennifer Louise Cornish, Iain S. McGregor · 2007 · Neuroscience
  41. Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
    S. Parker Singleton, Julie B. Wang, Michael C. Mithoefer, Colleen A. Hanlon, Mark S. George, Annie Mithoefer, Oliver J. Mithoefer, Allison R. Coker, Berra Yazar‐Klosinski, Amy Emerson et al. · 2023 · Frontiers in Psychiatry
  42. Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation
    Sara Garcia‐Ratés, Jordi Camarasa, Elena Escubedo, David Pubill · 2007 · Toxicology and Applied Pharmacology
  43. Involvement of mitochondrial/lysosomal toxic cross-talk in ecstasy induced liver toxicity under hyperthermic condition
    Jalal Pourahmad, Mohammad Reza Eskandari, Masoumeh Nosrati, Farzad Kobarfard, Ali Reza Khajeamiri · 2010 · European Journal of Pharmacology
  44. Evidence that MDMA (‘ecstasy’) increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain
    Elisa Torres, María Dolores Gutiérrez‐López, Érika Borcel, Inés Peraile, Andrea Mayado, Esther O’Shea, María Isabel Colado · 2010 · Journal of Neurochemistry
  45. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT
    Altaf S. Darvesh, Gary A. Gudelsky · 2005 · Brain Research
  46. Managing young people with Type 1 diabetes in a ‘rave’ new world: metabolic complications of substance abuse in Type 1 diabetes
    P. Lee, Jerry Richard Greenfield, Lesley V. Campbell · 2009 · Diabetic Medicine
  47. Mindfulness meditation and psychedelics: potential synergies and commonalities
    Holas, Paweł, Kamińska, Justyna · 2023 · Pharmacological Reports
  48. Recreational 3,4- methylenedioxy-N-methylamphetamine (MDMA) or ecstasy and self-focused compassion: preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices
    Kamboj, Sunjeev K, Kilford, Emma J, Minchin, Stephanie, Moss, Abigail, Lawn, Will, Das, Ravi K, Falconer, Caroline J, Gilbert, Paul, Curran, H Valerie, Freeman, Tom P · 2015 · Journal of Psychopharmacology
  49. Memantine prevents MDMA-induced neurotoxicity
    Carlos Chipana, Jorge Camarasa, David Pubill, Elena Escubedo · 2007 · NeuroToxicology
  50. Endocrine and Neurochemical Effects of 3,4-Methylenedioxymethamphetamine and Its Stereoisomers in Rhesus Monkeys
    Kevin Sean Murnane, William Edward Fantegrossi, J.R. Godfrey, Matthew L. Banks, Leonard Lee Howell · 2010 · Journal of Pharmacology and Experimental Therapeutics
  51. Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: Involvement of nicotinic receptors
    Carlos Chipana, Jorge Camarasa, David Pubill, Elena Escubedo · 2006 · Neuropharmacology
  52. Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy)
    Takayuki Nakagawa, Shuji Kaneko · 2008 · Journal of Pharmacological Sciences
  53. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain
    María Izco, Laura Orío, Esther O’Shea, M. Isabel Colado · 2006 · Psychopharmacology
  54. The hidden side of drug action: brain temperature changes induced by neuroactive drugs
    Eugene A. Kiyatkin · 2012 · Psychopharmacology
  55. Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine
    Esther O’Shea, Andrés Urrutia, A. Richard Green, M. Isabel Colado · 2014 · Neuropharmacology
  56. A Study on the Mechanisms by Which Minocycline Protects Against MDMA (‘Ecstasy’)-Induced Neurotoxicity of 5-HT Cortical Neurons
    Laura Orío, Noemi Llopis, Elisa Torres, María Izco, Esther O’Shea, María Isabel Colado · 2009 · Neurotoxicity Research
  57. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats
    Jorge Camarasa, José M. Marimón, Teresa Rodrigo, Elena Escubedo, David Pubill · 2008 · European Journal of Pharmacology
  58. The Neuropsychopharmacology and Toxicology of 3,4‐methylenedioxy‐N‐ethyl‐amphetamine (MDEA)
    Roland W. Freudenmann, Manfred Spitzer · 2004 · CNS Drug Reviews
  59. Methylenedioxymethamphetamine (‘Ecstasy’)‐induced immunosuppression: a cause for concern?
    Noreen T. Boyle, Thomas J. Connor · 2010 · British Journal of Pharmacology
  60. (±)3,4-Methylenedioxymethamphetamine, d-Amphetamine, and Cocaine Impair Delayed Matching-to-Sample Performance by an Increase in Susceptibility to Proactive Interference.
    David N. Harper, Regan Wisnewski, Maree J. Hunt, Susan Schenk · 2005 · Behavioral Neuroscience
  61. Learning and memory after neonatal exposure to 3,4‐methylenedioxymethamphetamine (ecstasy) in rats: Interaction with exposure in adulthood
    Martha A. Cohen, Matthew R. Skelton, Tori L. Schaefer, Gary A. Gudelsky, Charles V. Vorhees, Michael T. Williams · 2005 · Synapse
  62. (±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA
    Elizabeth G. Pitts, Daniel W. Curry, Karly N. Hampshire, Matthew B. Young, Leonard Lee Howell · 2017 · Psychopharmacology
  63. Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
    Hans Emanuel Oeri · 2020 · Journal of Psychopharmacology
  64. Drug instrumentalization
    Christian P. Müller · 2020 · Behavioural Brain Research
  65. Evaluation of drug incorporation into hair segments and nails by enantiomeric analysis following controlled single MDMA intakes
    Milena M. Madry, Andrea Eva Steuer, Cédric M. Hysek, Matthias E. Liechti, Markus R. Baumgartner, Thomas Kræmer · 2015 · Analytical and Bioanalytical Chemistry
  66. Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy
    Ana Rita Álvaro, João Martins, Ana Carolina Faria da Costa, Eduarda G. R. Fernandes, Félix Dias Carvalho, António Francisco Ambrósio, Cláudia Cavadas · 2007 · Neuroscience
  67. Paroxetine Inhibits Acute Effects of 3,4-Methylenedioxymethamphetamine on the Immune System in Humans
    Roberta Pacifici, Simona Pichini, Piergiorgio Zuccaro, Magı́ Farré, Mireia Segura, Jordi Ortuño, Simonetta Di Carlo, Antonella Bacosi, Pere Nolasc Roset, Jordi Segura et al. · 2004 · Journal of Pharmacology and Experimental Therapeutics
  68. Imaging brain activity in conscious monkeys following oral MDMA (“ecstasy”)
    Mathew E. Brevard, Jerrold S. Meyer, Josie A. Harder, Craig F. Ferris · 2006 · Magnetic Resonance Imaging
  69. Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects
    Andrew C. Parrott, Euphrosyne Gouzoulis‐Mayfrank, Jacqui Rodgers, Nadia Solowij · 2004 · Journal of Psychopharmacology
  70. MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology
    Patricio Sáez‐Briones, Alejandro Hernández · 2013 · Current Neuropharmacology
  71. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
    Lynn Taurah, Chris Chandler, Geoff Sanders · 2013 · Psychopharmacology
  72. α1-Adrenergic receptors mediate the locomotor response to systemic administration of (±)-3,4-methylenedioxymethamphetamine (MDMA) in rats
    Jennifer Selken, David E. Nichols · 2007 · Pharmacology Biochemistry and Behavior
  73. Meta-analysis of executive functioning in ecstasy/polydrug users
    Carl Alexander Roberts, Andrew Jones, Catharine Montgomery · 2016 · Psychological Medicine
  74. Interactions between 3,4-methylenedioxymethamphetamine and σ1 receptors
    Matthew K. Brammer, Deborah L. Gilmore, Rae R. Matsumoto · 2006 · European Journal of Pharmacology
  75. The rewarding properties of MDMA are preserved in mice lacking µ‐opioid receptors
    Patricia Robledo, Victoria E. Mendizábal, Jordi Ortuño, Rafael de la Torre, Brigitte Lina Kieffer, Rafael J. Maldonado · 2004 · European Journal of Neuroscience
  76. Influence of PCPA and MDMA (ecstasy) on physiology, development and behavior in Drosophila melanogaster
    Sameera Dasari, Kert Viele, Amy Turner, Robin Lewis Cooper · 2007 · European Journal of Neuroscience
  77. Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats
    Anna M. S. Kindlundh-Högberg, Anna Blomqvist, Rana Malki, Helgi B. Schiöth · 2008 · BMC Neuroscience
  78. Repeated Adolescent 3,4-Methylenedioxymethamphetamine (MDMA) Exposure in Rats Attenuates the Effects of a Subsequent Challenge with MDMA or a 5-Hydroxytryptamine1A Receptor Agonist
    Brian J. Piper, Huyen L. Vu, Mina G. Safain, Andrew J. Oliver, Jerrold S. Meyer · 2006 · Journal of Pharmacology and Experimental Therapeutics
  79. Mephedrone (4‐methylmethcathinone) and d‐methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques
    M. Jerry Wright, SA Vandewater, Deepshikha Angrish, TJ Dickerson, MA Taffe · 2012 · British Journal of Pharmacology
  80. Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)‐induced hyperthermia in rats
    Natacha Vanattou‐Saïfoudine, Ruth McNamara, Andrew Harkin · 2010 · British Journal of Pharmacology
  81. Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA)
    V. Buben kov, Martin Votava, J. Hora ek, T. P len ek · 2005 · Behavioural Pharmacology
  82. (+/–)3,4-Methylenedioxymethamphetamine (MDMA) Dose-Dependently Impairs Spatial Learning in the Morris Water Maze after Exposure of Rats to Different Five-Day Intervals from Birth to Postnatal Day Twenty
    Charles V. Vorhees, Tori L. Schaefer, Matthew R. Skelton, Curtis E. Grace, Nicole R. Herring, Michael T. Williams · 2009 · Developmental Neuroscience
  83. Oxytocin and MDMA (‘Ecstasy’) enhance social reward in rats
    Linnet Ramos, Callum Hicks, Alex Caminer, Jack Goodwin, Iain S. McGregor · 2015 · Psychopharmacology
  84. Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats
    Ratchanee Rodsiri, Clare H. Spicer, A. Richard Green, Charles Alexander Marsden, Kevin C.F. Fone · 2010 · Psychopharmacology
  85. Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone
    Sinead E. Shortall, Clare H. Spicer, Francis J. P. Ebling, A. Richard Green, Kevin C.F. Fone, Madeleine V. King · 2015 · Addiction Biology
  86. MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study
    Andrew C. Parrott, Amy Gibbs, Andrew B Scholey, Rebecca King, Katherine Owens, Phil Swann, Edward Ogden, Con K. K. Stough · 2011 · Psychopharmacology
  87. Mephedrone and MDMA: A comparative review
    Jessica Mead, Andrew Parrott · 2020 · Brain Research
  88. Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes
    Grant M. Jones, Matthew K. Nock · 2022 · Journal of Psychopharmacology
  89. Effects of Dopamine- and Serotonin-Related Compounds on Methamphetamine-Induced Self-Injurious Behavior in Mice
    Tomohisa Mori, Shinobu Ito, Taizo Kita, Toshiko Sawaguchi · 2004 · Journal of Pharmacological Sciences
  90. Neural Effects of MDMA as Determined by Functional Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Awake Marmoset Monkeys
    Jerrold S. Meyer, Mathew E. Brevard, Brian J. Piper, Syed F. Ali, Craig F. Ferris · 2006 · Annals of the New York Academy of Sciences
  91. Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?
    Werner Schmidt, Andreas Mayerhofer, Anja Meyer, Karl-A. Kovar · 2002 · Neuroscience Letters
  92. Chapter 3 Monoamine Transporter as a Target Molecule for Psychostimulants
    Ichiro Sora, Bingjin Li, Setsu Fumushima, Asami Fukui, Yosefu Arime, Yoshiyuki Kasahara, Hiroaki Tomita, Kazutaka Ikeda · 2009 · International review of neurobiology
  93. Examining the role of oxytocin in the interoceptive effects of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat
    Jillian Helen Broadbear, Brendan J. Tunstall, Katherine Beringer · 2010 · Addiction Biology
  94. Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs
    Ichiro Sora, BingJin Li, Moe Igari, Frank Scott Hall, Kazutaka Ikeda · 2010 · Annals of the New York Academy of Sciences
  95. Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects
    Sami Ben Hamida, Erin Plute, Brigitte Cosquer, Christian R. Kelche, Byron C. Jones, Jean‐Christophe Cassel · 2007 · Psychopharmacology
  96. Behavioral and growth effects induced by low dose methamphetamine administration during the neonatal period in rats
    Michael T. Williams, Mary S. Moran, Charles V. Vorhees · 2004 · International Journal of Developmental Neuroscience
  97. Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour
    María Juliana Orejarena, Laurence Lanfumey, Rafael J. Maldonado, Patricia Robledo · 2010 · The International Journal of Neuropsychopharmacology
  98. Disposition of MDMA and Metabolites in Human Sweat Following Controlled MDMA Administration
    Allan J. Barnes, Bruno Spinosa De Martinis, David A. Gorelick, Robert S. Goodwin, Erin A Kolbrich, Marilyn Ann Huestis · 2009 · Clinical Chemistry
  99. Developmental effects of ±3,4‐methylenedioxymethamphetamine on spatial versus path integration learning: Effects of dose distribution
    Charles V. Vorhees, Tori L. Schaefer, Michael T. Williams · 2007 · Synapse
  100. Effects of (±)3,4-methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques
    Rebecca D. Crean, Sophia A. Davis, Stefani N. Von Huben, Christopher C. Lay, Simon N. Katner, Michael A. Taffe · 2006 · Neuroscience